Option Care Health, Inc. (OPCH)
USD 32.18
(0.22%)
USD 32.18
(0.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 981.22 Million USD | 6.36% |
| 2022 | 866.91 Million USD | 11.2% |
| 2021 | 779.6 Million USD | 14.27% |
| 2020 | 682.26 Million USD | 33.0% |
| 2019 | 512.99 Million USD | 111.08% |
| 2018 | 243.03 Million USD | -10.43% |
| 2017 | 271.33 Million USD | 2.15% |
| 2016 | 265.63 Million USD | 1.81% |
| 2015 | 260.91 Million USD | -0.06% |
| 2014 | 261.06 Million USD | -3.95% |
| 2013 | 271.81 Million USD | 20.83% |
| 2012 | 224.96 Million USD | -27.97% |
| 2011 | 312.3 Million USD | 19.92% |
| 2010 | 260.41 Million USD | 65.01% |
| 2009 | 157.82 Million USD | 11.01% |
| 2008 | 142.17 Million USD | 3.76% |
| 2007 | 137.01 Million USD | 14.57% |
| 2006 | 119.59 Million USD | 2.86% |
| 2005 | 116.26 Million USD | 70.59% |
| 2004 | 68.15 Million USD | -0.53% |
| 2003 | 68.52 Million USD | -2.94% |
| 2002 | 70.59 Million USD | 32.2% |
| 2001 | 53.4 Million USD | 38.33% |
| 2000 | 38.6 Million USD | 18.93% |
| 1999 | 32.46 Million USD | 4.38% |
| 1998 | 31.1 Million USD | 606.82% |
| 1997 | 4.4 Million USD | -25.42% |
| 1996 | 5.9 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 234.45 Million USD | -1.69% |
| 2024 Q1 | 238.5 Million USD | 2.65% |
| 2024 Q3 | 256.74 Million USD | 9.51% |
| 2023 FY | 922.02 Million USD | 6.36% |
| 2023 Q1 | 229 Million USD | -0.9% |
| 2023 Q2 | 250.82 Million USD | 9.53% |
| 2023 Q3 | 254.26 Million USD | 1.37% |
| 2023 Q4 | 232.33 Million USD | -8.62% |
| 2022 Q3 | 218 Million USD | 0.51% |
| 2022 Q4 | 231.08 Million USD | 6.0% |
| 2022 Q1 | 200.93 Million USD | -5.31% |
| 2022 Q2 | 216.9 Million USD | 7.94% |
| 2022 FY | 866.91 Million USD | 11.2% |
| 2021 Q3 | 202.96 Million USD | 2.01% |
| 2021 Q4 | 212.19 Million USD | 4.55% |
| 2021 Q1 | 165.47 Million USD | -9.95% |
| 2021 FY | 779.6 Million USD | 14.27% |
| 2021 Q2 | 198.96 Million USD | 20.24% |
| 2020 Q3 | 174.15 Million USD | 4.71% |
| 2020 Q1 | 158.02 Million USD | -10.03% |
| 2020 Q2 | 166.32 Million USD | 5.25% |
| 2020 Q4 | 183.76 Million USD | 5.52% |
| 2020 FY | 682.26 Million USD | 33.0% |
| 2019 Q1 | 57.66 Million USD | -7.18% |
| 2019 Q4 | 175.64 Million USD | 27.49% |
| 2019 Q3 | 137.77 Million USD | 113.1% |
| 2019 Q2 | 64.65 Million USD | 12.12% |
| 2019 FY | 512.99 Million USD | 111.08% |
| 2018 Q4 | 62.12 Million USD | -5.75% |
| 2018 Q2 | 59.95 Million USD | 8.92% |
| 2018 Q1 | 55.04 Million USD | -21.65% |
| 2018 FY | 243.03 Million USD | -10.43% |
| 2018 Q3 | 65.91 Million USD | 9.93% |
| 2017 FY | 271.33 Million USD | 2.15% |
| 2017 Q2 | 68.31 Million USD | 4.16% |
| 2017 Q3 | 67.17 Million USD | -1.66% |
| 2017 Q4 | 70.26 Million USD | 4.59% |
| 2017 Q1 | 65.58 Million USD | -12.14% |
| 2016 FY | 265.63 Million USD | 1.81% |
| 2016 Q3 | 62.58 Million USD | -2.46% |
| 2016 Q2 | 64.16 Million USD | -0.11% |
| 2016 Q1 | 64.23 Million USD | -2.54% |
| 2016 Q4 | 74.65 Million USD | 19.28% |
| 2015 Q2 | 65.96 Million USD | -0.76% |
| 2015 Q3 | 63.14 Million USD | -4.28% |
| 2015 Q4 | 65.9 Million USD | 4.38% |
| 2015 FY | 260.91 Million USD | -0.06% |
| 2015 Q1 | 66.47 Million USD | 1.32% |
| 2014 Q4 | 65.6 Million USD | 0.93% |
| 2014 Q2 | 65.35 Million USD | 0.33% |
| 2014 FY | 261.06 Million USD | -3.95% |
| 2014 Q1 | 65.14 Million USD | -13.01% |
| 2014 Q3 | 65 Million USD | -0.54% |
| 2013 Q3 | 68.68 Million USD | 5.65% |
| 2013 Q4 | 74.88 Million USD | 9.03% |
| 2013 FY | 271.81 Million USD | 20.83% |
| 2013 Q1 | 63.23 Million USD | 4.71% |
| 2013 Q2 | 65.01 Million USD | 2.81% |
| 2012 Q2 | 53.04 Million USD | -0.9% |
| 2012 Q4 | 60.39 Million USD | 4.12% |
| 2012 Q1 | 53.52 Million USD | -34.54% |
| 2012 FY | 224.96 Million USD | -27.97% |
| 2012 Q3 | 58 Million USD | 9.36% |
| 2011 Q2 | 76.22 Million USD | -1.35% |
| 2011 Q3 | 77.06 Million USD | 1.11% |
| 2011 Q1 | 77.26 Million USD | 6.44% |
| 2011 Q4 | 81.75 Million USD | 6.09% |
| 2011 FY | 312.3 Million USD | 19.92% |
| 2010 Q2 | 73.52 Million USD | 88.92% |
| 2010 FY | 260.41 Million USD | 65.01% |
| 2010 Q4 | 72.59 Million USD | -3.7% |
| 2010 Q1 | 38.91 Million USD | -7.22% |
| 2010 Q3 | 75.38 Million USD | 2.53% |
| 2009 Q3 | 41.49 Million USD | 8.1% |
| 2009 FY | 157.82 Million USD | 11.01% |
| 2009 Q4 | 41.94 Million USD | 1.09% |
| 2009 Q2 | 38.38 Million USD | 6.66% |
| 2009 Q1 | 35.99 Million USD | -5.27% |
| 2008 FY | 142.17 Million USD | 3.76% |
| 2008 Q4 | 37.99 Million USD | 5.29% |
| 2008 Q1 | 32.37 Million USD | -7.68% |
| 2008 Q2 | 35.72 Million USD | 10.36% |
| 2008 Q3 | 36.08 Million USD | 0.99% |
| 2007 Q1 | 32.94 Million USD | 7.09% |
| 2007 FY | 137.01 Million USD | 14.57% |
| 2007 Q4 | 35.06 Million USD | -1.73% |
| 2007 Q3 | 35.68 Million USD | 7.09% |
| 2007 Q2 | 33.32 Million USD | 1.13% |
| 2006 Q1 | 30.33 Million USD | -9.7% |
| 2006 Q2 | 28.79 Million USD | -5.06% |
| 2006 Q3 | 29.7 Million USD | 3.16% |
| 2006 Q4 | 30.76 Million USD | 3.58% |
| 2006 FY | 119.59 Million USD | 2.86% |
| 2005 FY | 116.26 Million USD | 70.59% |
| 2005 Q1 | 20.44 Million USD | 16.12% |
| 2005 Q2 | 30.51 Million USD | 49.23% |
| 2005 Q3 | 31.71 Million USD | 3.95% |
| 2005 Q4 | 33.58 Million USD | 5.89% |
| 2004 Q2 | 16.85 Million USD | -0.67% |
| 2004 Q3 | 16.73 Million USD | -0.69% |
| 2004 Q4 | 17.6 Million USD | 5.22% |
| 2004 Q1 | 16.96 Million USD | 11.24% |
| 2004 FY | 68.15 Million USD | -0.53% |
| 2003 Q1 | 18.6 Million USD | -2.9% |
| 2003 Q4 | 15.25 Million USD | -0.94% |
| 2003 Q3 | 15.39 Million USD | -20.13% |
| 2003 Q2 | 19.27 Million USD | 3.62% |
| 2003 FY | 68.52 Million USD | -2.94% |
| 2002 Q3 | 17.96 Million USD | 2.96% |
| 2002 Q4 | 19.15 Million USD | 6.64% |
| 2002 Q2 | 17.44 Million USD | 8.86% |
| 2002 Q1 | 16.02 Million USD | 9.2% |
| 2002 FY | 70.59 Million USD | 32.2% |
| 2001 Q3 | 13.65 Million USD | 1.65% |
| 2001 Q4 | 14.67 Million USD | 7.48% |
| 2001 Q1 | 11.63 Million USD | -6.3% |
| 2001 Q2 | 13.43 Million USD | 15.45% |
| 2001 FY | 53.4 Million USD | 38.33% |
| 2000 Q2 | 9.09 Million USD | 20.57% |
| 2000 Q4 | 12.41 Million USD | 30.11% |
| 2000 Q3 | 9.54 Million USD | 4.92% |
| 2000 FY | 38.6 Million USD | 18.93% |
| 2000 Q1 | 7.54 Million USD | -4.02% |
| 1999 Q2 | 8.2 Million USD | -3.53% |
| 1999 Q4 | 7.86 Million USD | -0.49% |
| 1999 Q3 | 7.9 Million USD | -3.66% |
| 1999 Q1 | 8.5 Million USD | -16.67% |
| 1999 FY | 32.46 Million USD | 4.38% |
| 1998 Q4 | 10.2 Million USD | 21.43% |
| 1998 FY | 31.1 Million USD | 606.82% |
| 1998 Q1 | 6 Million USD | 200.0% |
| 1998 Q2 | 6.5 Million USD | 8.33% |
| 1998 Q3 | 8.4 Million USD | 29.23% |
| 1997 Q4 | -6 Million USD | -400.0% |
| 1997 Q3 | 2 Million USD | -51.22% |
| 1997 Q2 | 4.1 Million USD | -2.38% |
| 1997 Q1 | 4.2 Million USD | 220.0% |
| 1997 FY | 4.4 Million USD | -25.42% |
| 1996 FY | 5.9 Million USD | 0.0% |
| 1996 Q1 | 67.7 Million USD | 0.0% |
| 1996 Q4 | -3.5 Million USD | -185.37% |
| 1996 Q3 | 4.1 Million USD | -93.94% |
| 1996 Q2 | 67.7 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | -43.746% |
| Addus HomeCare Corporation | 339.87 Million USD | -188.7% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -704.908% |
| Amedisys, Inc. | 457.07 Million USD | -114.673% |
| American Oncology Network, Inc. | 66.05 Million USD | -1385.419% |
| Astrana Health, Inc. | 214.95 Million USD | -356.472% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | -64.792% |
| IMAC Holdings, Inc. | 3.84 Million USD | -25395.464% |
| biote Corp. | 127.48 Million USD | -669.689% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -4184.557% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | -127.102% |
| COMPASS Pathways plc | -242.93 Thousand USD | 403998.526% |
| DocGo Inc. | 178.95 Million USD | -448.321% |
| The Ensign Group, Inc. | 590.75 Million USD | -66.095% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -290.226% |
| InnovAge Holding Corp. | 132.06 Million USD | -642.991% |
| Assure Holdings Corp. | -2.19 Million USD | 44823.017% |
| The Joint Corp. | 107.14 Million USD | -815.749% |
| LifeStance Health Group, Inc. | 302.09 Million USD | -224.805% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 91662.318% |
| ModivCare Inc. | 446.95 Million USD | -119.537% |
| NewGenIvf Group Limited | 1.68 Million USD | -58244.14% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -19711.82% |
| P3 Health Partners Inc. | 31.63 Million USD | -3001.701% |
| P3 Health Partners Inc. | 31.63 Million USD | -3001.701% |
| The Pennant Group, Inc. | 61.9 Million USD | -1485.021% |
| Surgery Partners, Inc. | 529.4 Million USD | -85.346% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -69396.636% |
| Talkspace, Inc. | 74.38 Million USD | -1219.203% |
| Talkspace, Inc. | 74.38 Million USD | -1219.203% |
| The Oncology Institute, Inc. | 59.57 Million USD | -1547.093% |
| The Oncology Institute, Inc. | 59.57 Million USD | -1547.093% |